share_log

SAB Biotherapeutics | 10-K: FY2022 Annual Report

SEC ·  Apr 15, 2023 04:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more